Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic Encephalopathy

This study has been terminated.

( Study was terminated due to lack of enrollment and businesss decisions. )

Study NCT00597909 Information provided by Hyperion Therapeutics, Inc.

First Received: January 9, 2008 Last Updated: July 14, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been terminated.
Study Completion Date:	September 2008
Primary Completion Date:	September 2008 (Final data collection date for primary outcome measure)